Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

57%

4 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 2
3(42.9%)
Phase 3
3(42.9%)
Phase 4
1(14.3%)
7Total
Phase 2(3)
Phase 3(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07381530Phase 2Suspended

Study of Cardioplegia in Cardiac Surgery Due to Congenital Heart Malformation in Children

Role: lead

NCT06032195Phase 2Recruiting

Study of Organ Perfusion in Heart Transplantation in Children

Role: lead

NCT03627013Phase 3Recruiting

Custodiol-N Solution Compared With Custodiol Solution in Organ Transplantation (Kidney, Liver and Pancreas)

Role: lead

NCT02098772Phase 3Completed

Phase III Study Comparing Two Methods of Cardioplegia in Aortic Valve Surgery Custodiol-N Versus Custodiol

Role: lead

NCT02869022Phase 3Completed

Study of Organ Perfusion With Custodiol-N Solution Compared With Custodiol Solution in Heart Transplantation

Role: lead

NCT01444235Phase 2Completed

Phase III Study Comparing Two Methods of Cardioplegia in Coronary Artery Bypass Surgery

Role: lead

NCT00737880Phase 4Completed

Histidine-Tryptophane-Ketoglutarate (HTK) vs University of Wisconsin (UW) Perfusion in Clinical Pancreas Transplantation

Role: collaborator

All 7 trials loaded